INCY

#552
Incyte Corporation - Common Stock
96.7 4 USD
-0.76%
版块: 医疗保健
基础: USD
利润货币: USD
日范围
96.74
96.76
年范围
63.92
112.29
日变化
-0.76%
每月变动
-3.58%
6个月变化
-6.34%
年变化
+47.22%
前一天收盘价
97.4 8
Open
96.7 6
最低价
96.7 4
High
96.7 6
交易量
577
展开完整图表 完整图表

Financials

概览 声明 统计
每季度 年度
  • Market Capitalization 19.33 B
  • Employee 2 844
  • Founded 2002
  • CEO Hervé Hoppenot
  • Website www.incyte.com
  • Headquarter Delaware, United States
  • FIGI BBG000BNPSQ9
  • Industry 生物技术
总收入
净利润
每股基本收益（基本 EPS）
总债务
自由现金流
现金及现金等价物
市盈率
15.41
市销率
3.86

Incyte Corporation - Common Stock

Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia. Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity.

新闻